Excited to be a collaborator on this study being led by @ShirleyCoMekMD along with @MPrasadMD and #CaitlinCitti @VAHouston @IQuEStHouston @UMichGIHep @VA_CCMR @VAAnnArbor @AtlantaVAMC @vaportland

RT @bcm_gihep: Considering crushing the GI Boards? Join us [free for residents and fellows] @AASLDtweets @AmCollegeGastro @ASGEendoscopy @…

RT @swatigp: ‼️ Ever feel 😬 or 💀 about interactions with Boomers👵🏽, Gen Xers🧔🏻, Millennials👨🏽, or Gen Zers🧑‍🦰? @JenKolbMD, Liz Magnan, Jo…

@ruben_hernaez @BCM_InternalMed @DrBloodandGuts @bcm_gihep @NataliaKhalaf Haha i did not look like that in 2006. I think they lost my photo

RT @BCMDeptMedicine: Congratulations to Dr. Fasiha Kanwal on being awarded the Nancy Chang, Ph.D. Endowed Professorship II. A true leader i…

Who better than one of the guideline authors @KanwalFasiha to present changes in #MASLD at #BCMGICourse @bcm_gihep ⭐️ new name with real changes ⭐️ screening with a purpose- actual treatment option available

Periop IBD management and decision on when to refer to surgery by #JaredSninsky one of our newest IBD docs at @bcm_gihep at the #BCMGICourse ⭐️ just because we have more medical options doesn’t mean we have to use them before surgery @AtifIqbalMD @khalil_rojas

@bcm_gihep GI Course director @ReenaChokshiMD clarifying off or on PPI when testing for GERD

Great talk/standup comedy routine by @BrennanSpiegel on constipation. @bcm_gihep GI Course ⭐️ got to take the cap off the toothpaste ⭐️ perineal massage supported by RCT @WasAbiDoc @ReenaChokshiMD

The boss @SeragHashem nicely summarizing approach to functional dyspepsia at the @bcm_gihep GI Course. @WasAbiDoc @ReenaChokshiMD

Course co-director @WasAbiDoc kicking off the @bcm_gihep GI&Liver course 2023 on anesthesia and GLP-1 Agonists.

RT @CrohnsColitisFn: Heard of IBD Qorus, the Foundation’s quality improvement program? Put simply, it's a network of GI providers working t…

#IBD care in @DeptVetAffairs has come a long way ⭐️ Access to IBD advanced therapy at low or no cost ⭐️ IBD providers in VA throughout the country ⭐️ Thanks to collaboration with the @CrohnsColitisFn to help educate on #veteran access:

First ever national VA #IBD Bootcamp live right now! Wonderful learning opportunity to better serve our #Veterans with #Crohn’s and #ulcerativecolitis Over 200 attendees online! 🤩 @VAHouston @DeptVetAffairs @CrohnsColitisFn @EPaineMD @MPrasadMD @JasonDominitz @TadDryden

Great summary of update of #ECCO Crohn’s guidelines by @IBD_MB on closing day of #ECCO2024 ⭐️ Move away from term “conventional therapy” ⭐️ Many med options: How to choose? Interesting despite all progress in recent years- IFX is only agent recommended in all scenarios

More Head-2-head Crohn’s data #ECCO2024 with @MarlaDubinsky presenting clinical outcomes from #SEQUENCE RISA vs. UST ⭐️ All TNFi failure pts ⭐️ RISA > UST Clinical Remission @ wk 48 (🔼~20%) ⭐️ Separation of curves for Sx improvement as early as wk 8, continue through wk 24

VIVID-1 MIRI vs. UST for CD ⭐️ Main difference (🔼~10%) apparently in bio failure, pretty close in bio naive pts. ⭐️ Interestingly similar to SEQUENCE (RISA vs. UST) which was all bio exposed Looks like overall IL-23 > in TNFi failures, but IL-23~ UST for TNFi naive

ADMIRE-CD 2 perhaps high placebo response due to most pts (90%) on biologic or bio combo w/ IS